About
SpectraWAVE, Inc. is a medical device company based in Bedford, Massachusetts, founded in 2017. The company focuses on advanced intravascular imaging technology to enhance the treatment of coronary artery disease (CAD). Its flagship product, the HyperVue™ Imaging System, combines DeepOCT (optical coherence tomography) imaging with near infrared spectroscopy (NIRS). This innovative system provides detailed images of coronary artery structure and lipid content, aiding physicians in making informed decisions during procedures like stent placement. The HyperVue system is designed to improve workflows in cardiac catheterization labs, facilitating efficient image acquisition and interpretation. It helps identify plaques and assess patients' risk of major adverse cardiac events, supporting better treatment planning. SpectraWAVE has secured significant funding, including a $50 million Series B round led by Johnson & Johnson Innovation - JJDC, to further its commercial growth and product development. The company aims to enhance patient care in interventional cardiology by providing actionable imaging information to interventional cardiologists and cardiac catheterization labs.
Technologies
Keywords
Company Information
-
Employees 74
-
Founded 2017
-
Total Funding $79597066
Location
12 Oak Park Dr, Bedford, Massachusetts, United States, 01730-1414